New Law Expands Coverage for Biomarker Testing in Cancer Patients – Starting 2022

A cancer advocacy group is applauding a new law in Illinois involving biomarker testing.

Biomarker testing, the medical technology used to determine medical risk factors like cancer, will now be covered under Medicaid as well as state-regulated insurance plans.

Source: https://www.thecentersquare.com/illinois/new-law-expands-coverage-for-biomarker-testing-in-cancer-patients/article_3ff4664c-f626-11eb-8e90-c793beffe43b.html